Search research articles
Contact Us
Filters
Showing results (221-230 of 551) with videos related to
Page
of 56
Sort By:
The New England Journal of Medicine
|
May 25, 1995
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
R Lotan, X C Xu, S M Lippman, et al.
American Journal of Hematology
|
May 1, 1985
Mitral valve prolapse in sickle cell disease: manifestation of a generalized connective tissue disorder
S M Lippman, R P Abergel, L E Ginzton, et al.
Cancer Research
|
December 1, 1995
Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression
X C Xu, M H Zile, S M Lippman, et al.
Journal of the National Cancer Institute
|
January 6, 1993
Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study
S E Benner, R J Winn, S M Lippman, et al.
International Journal of Cancer
|
August 19, 1992
Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis
S E Benner, S M Lippman, M J Wargovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity
I W Dimery, W K Hong, J J Lee, et al.
American Journal of Clinical Oncology
|
August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck
M H Huber, S M Lippman, S E Benner, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Results of the National Cancer Institute early breast cancer trial
K Straus, A Lichter, M Lippman, et al.
Cancer Research
|
May 1, 1992
Determination of biomarkers for intermediate end points in chemoprevention trials
J S Lee, S M Lippman, W K Hong, et al.
Oral Oncology
|
September 19, 2003
Molecular based treatment of oral cancer
Jon Sudbø, Magne Bryne, Li Mao, et al.
Page
of 56
Search research articles
Search
Showing results (221-230 of 551) with videos related to
Sort By:
Page
of 56
The New England Journal of Medicine
|
May 25, 1995
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
R Lotan, X C Xu, S M Lippman, et al.
American Journal of Hematology
|
May 1, 1985
Mitral valve prolapse in sickle cell disease: manifestation of a generalized connective tissue disorder
S M Lippman, R P Abergel, L E Ginzton, et al.
Cancer Research
|
December 1, 1995
Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression
X C Xu, M H Zile, S M Lippman, et al.
Journal of the National Cancer Institute
|
January 6, 1993
Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study
S E Benner, R J Winn, S M Lippman, et al.
International Journal of Cancer
|
August 19, 1992
Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis
S E Benner, S M Lippman, M J Wargovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity
I W Dimery, W K Hong, J J Lee, et al.
American Journal of Clinical Oncology
|
August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck
M H Huber, S M Lippman, S E Benner, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Results of the National Cancer Institute early breast cancer trial
K Straus, A Lichter, M Lippman, et al.
Cancer Research
|
May 1, 1992
Determination of biomarkers for intermediate end points in chemoprevention trials
J S Lee, S M Lippman, W K Hong, et al.
Oral Oncology
|
September 19, 2003
Molecular based treatment of oral cancer
Jon Sudbø, Magne Bryne, Li Mao, et al.
Page
of 56